NASDAQ: ZBIOZenas Biopharma Inc Stock Ownership - Who owns Zenas Biopharma?
Insider buying vs selling
Have Zenas Biopharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Leon O. Moulder Jr. | Chief Executive Officer | 2025-02-18 | 25,000 | $6.67 | $166.75kBuy |
| Ting Xiao | Director | 2025-02-07 | 10,000 | $7.76 | $77.60kBuy |
| Ting Xiao | Director | 2025-02-07 | 10,000 | $7.76 | $77.60kBuy |
| Leon O. Moulder Jr. | Chief Executive Officer | 2024-12-04 | 45,000 | $9.98 | $449.10kBuy |
| Leon O. Moulder Jr. | Chief Executive Officer | 2024-12-03 | 25,000 | $10.76 | $269.00kBuy |
| Leon O. Moulder Jr. | Chief Executive Officer | 2024-11-19 | 2,500 | $14.57 | $36.43kBuy |
| Leon O. Moulder Jr. | Chief Executive Officer | 2024-11-18 | 7,500 | $15.00 | $112.50kBuy |
ZBIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ZBIO insiders and whales buy or sell their stock.
ZBIO Shareholders
What type of owners hold Zenas Biopharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Sr One Capital Management LP | 11.74% | 4,911,539 | $44.89M | Institution |
| Enavate Sciences GP LLC | 8.99% | 3,761,359 | $34.38M | Institution |
| Fmr LLC | 6.82% | 2,852,371 | $26.07M | Institution |
| Nea Management Company LLC | 6.25% | 2,613,948 | $23.89M | Institution |
| Novo Holdings A | 5.29% | 2,214,967 | $20.24M | Institution |
| Leon O. Moulder Jr. | 4.63% | 1,938,194 | $17.72M | Insider |
| Fairmount Funds Management LLC | 4.52% | 1,892,806 | $17.30M | Institution |
| Nvp Associates LLC | 4.39% | 1,838,482 | $16.80M | Institution |
| Deerfield Management Company LP Series C | 3.74% | 1,562,942 | $14.29M | Institution |
| Vivo Capital LLC | 2.83% | 1,183,260 | $10.81M | Institution |
ZBIO vs Biotech Stocks
Zenas Biopharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.